Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke

Stroke

Volumn 37, Issue 7, 2006, Pages 1749-1753

  Price, Christopher J S ^a,b   Wang, Dechao ^b   Menon, David K ^b   Guadagno, Joe V ^b   Cleij, Marcel ^b   Fryer, Tim ^b   Aigbirhio, Franklin ^b   Baron, Jean Claude ^b   Warburton, Elizabeth A ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Inflammation; Microglia; Positron emission tomography; Tomograpy, emission computed

Indexed keywords

N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; 4 AMINOBUTYRIC ACID RECEPTOR; BZRP PROTEIN, HUMAN; CARBON; DIAGNOSTIC AGENT; ISOQUINOLINE DERIVATIVE; NERVE PROTEIN; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BLOOD VOLUME; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN MAPPING; CASE REPORT; CELL ACTIVATION; CEREBELLUM; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MICROGLIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ACUTE DISEASE; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; METABOLISM; PATHOLOGY; PROTEIN BINDING; SCINTISCANNING; TIME;

ACUTE DISEASE; ADULT; AGED; BRAIN ISCHEMIA; CARBON RADIOISOTOPES; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISOQUINOLINES; MALE; MICROGLIA; NERVE TISSUE PROTEINS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOPHARMACEUTICALS; RECEPTORS, GABA; TIME FACTORS;

EID: 33745942789     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000226980.95389.0b     Document Type: Article

References (24)

1. Danton GH, Dietrich WD. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol. 2003;62:127-136.
2. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A. 1999;96:13496-13500.
3. Rothwell N. Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav Immun. 2003;17:152-157.
4. Price CJ, Warburton EA, Menon DK. Human cellular inflammation in the pathology of acute cerebral ischaemia. J Neurol Neurosurg Psychiatry. 2003;74:1476-1484.
5. Zhang Z, Chopp M, Powers C. Temporal profile of microglial response following transient (2 h) middle cerebral artery occlusion. Brain Res. 1997;744:189-198.
6. Mabuchi T, Kitagawa K, Ohtsuki T, Kuwabara K, Yagita Y, Yanagihara T, Hori M, Matsumoto M. Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke. 2000;31:1735-1743.
7. Dubois A, Benavides J, Peny B, Duverger D, Fage D, Gotti B, MacKenzie ET, Scatton B. Imaging of primary and remote ischaemic and excitotoxic brain lesions: an autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat. Brain Res. 1988;445:77-90.
8. Banati RB, Myers R, Kreutzberg GW. PK ('peripheral benzodiazepine')- binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J Neurocytol. 1997;26:77-82.
9. Sette G, Baron JC, Young AR, Miyazawa H, Tillet I, Barre L, Travere JM, Derlon JM, MacKenzie ET. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke. 1993;24:2046-2057; discussion 2057-2058.
10. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage. 2005;24:591-595.
11. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6:279-287.
12. Marchal G, Benali K, Iglesias S, Viader F, Derlon JM, Baron JC. Voxel-based mapping of irreversible ischaemic damage with PET in acute stroke. Brain. 1999;122 (pt 12):2387-2400.
13. Wang D, Price CJS, Green H, Menon DK, Cleij M, Aigbirhio FI, Warburton EA, Baron JC. CBV correction of 11C-PK11195 binding potential in ischaemic stroke using simplified reference models. Neuroimage. 2004;22(suppl 2):96-97.
14. Sette G, Baron JC, Mazoyer B, Levasseur M, Pappata S, Crouzel C. Local brain haemodynamics and oxygen metabolism in cerebrovascular disease: positron emission tomography. Brain. 1989;112(pt 4):931-951.
15. Phan TG, Donnan GA, Wright PM, Reutens DC. A digital map of middle cerebral artery infarcts associated with middle cerebral artery trunk and branch occlusion. Stroke. 2005;36:986-991.
16. Baron JC, Bousser MG, Comar D. Crossed cerebellar diaschisis in human supratentorial brain infarction. Ann Neurol. 1980;8:128.
17. Lockhart A, Davis B, Matthews JC, Rahmoune H, Hong G, Gee A, Earnshaw D, Brown J. The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant α1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker. Nucl Med Biol. 2003;30:199-206.
18. Benavides J, Capdeville C, Dauphin F, Dubois A, Duverger D, Fage D, Gotti B, MacKenzie ET, Scatton B. The quantification of brain lesions with an omega 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration. Brain Res. 1990;522:275-289.
19. Schroeter M, Jander S, Huitinga I, Witte OW, Stoll G. Phagocytic response in photochemically induced infarction of rat cerebral cortex: the role of resident microglia. Stroke. 1997;28:382-386.
20. Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, Jones T, Kreutzberg GW, Banati RB. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology. 2000;55:1052-1054.
21. Myers R, Manjil LG, Frackowiak RS, Cremer JE. [3H]PK 11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex. Neurosci Lett. 1991;133:20-24.
22. Saleh A, Schroeter M, Jonkmanns C, Hartung HP, Modder U, Jander S. In vivo MRI of brain inflammation in human ischaemic stroke. Brain. 2004;127(pt 7):1670-1677.
23. Price CJ, Menon DK, Peters AM, Ballinger JR, Barber RW, Balan KK, Lynch A, Xuereb JH, Fryer T, Guadagno JV, Warburton EA. Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study. Stroke. 2004;35:1659-1664.
24. Wahlgren NG, Ahmed N. Neuroprotection in cerebral ischaemia: facts and fancies: the need for new approaches. Cerebrovasc Dis. 2004;17(suppl 1):153-166.